Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes

American Journal of Pathology

Volumn 170, Issue 2, 2007, Pages 478-489

  Lázaro, Catherine A ^a   Chang, Ming ^a   Tang, Weiliang ^a   Campbell, Jean ^a   Sullivan, Daniel G ^a   Gretch, David R ^a   Corey, Lawrence ^a   Coombs, Robert W ^a   Fausto, Nelson ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CORE PROTEIN; ENVELOPE PROTEIN; GAMMA INTERFERON; VIRUS RNA; INTERFERON;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOTOXICITY; ELECTRON MICROSCOPY; FETUS; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUCROSE DENSITY GRADIENT CENTRIFUGATION; SUPERNATANT; VIRUS PARTICLE; VIRUS REPLICATION; BIOSYNTHESIS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SERUM; VIROLOGY;

CELLS, CULTURED; FETUS; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INTERFERONS; RNA, VIRAL; SERUM; TRANSFECTION; VIRUS REPLICATION;

EID: 33947507817     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060789     Document Type: Article

References (44)

1. Wasley A, Alter MJ: Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20:1-16
2. Seeff LB: Natural history of hepatitis C. Am J Med 1999, 107:10S-15S
3. Williams I: Epidemiology of hepatitis C in the United States. Am J Med 1999, 107:2S-9S
4. Alter MJ: Hepatitis C virus infection in the United States. J Hepatol 1999, 31(Suppl 1):88-91
5. Kato N, Shimotohno K: Systems to culture hepatitis C virus. Curr Top Microbiol Immunol 2000, 242:261-278
6. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H: Evidence for in vitro replication of hepatitic C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992, 89:5477-5481
7. Noguchi M, Hirohashi S: Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell Dev Biol Anim 1996, 32:135-137
8. lacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, Macioce G, Hassan HJ, Ponzetto A, Clementi M, Peschle C, Carloni G: Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997, 26:1328-1337
9. Loriot MA: Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 1999, 29:1587-1595
10. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113
11. Lohmann V, Korner F, Dobierzewska A, Bartenschlager R: Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 2001, 75:1437-1449
12. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R: Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 2002, 76:4008-4021
13. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M, Wakita T: Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003, 125:1808-1817
14. Date T: Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells J Biol Chem 2004, 279:22371-22376
15. Kato T: Non-hepatic cell lines HeLa and 293 cells support efficient replication of hepatitis C virus genotype 2a subgenomic replicon. J Virol 2005, 79:592-596
16. Wakita T, Pietschmann T, Kato T, DateT, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-796
17. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005, 102:9294-9299
18. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626
19. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R: Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006, 103:7408-7413
20. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM: Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 2006, 103:3805-3809
21. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM: Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 2006, 103:2310-2315
22. Berke JM, Moradpour D: Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture. Hepatology 2005, 42:1264-1269
23. Lazaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, Foraker J, Rhim JA, Yeoh GCT, Fausto N: establishment, characterization and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 2003, 38:1095-1106
24. Dan YY, Riehle KJ, Lazaro C, Teoh N, Haque J, Campbell JS, Fausto N: Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA 2006, 103:9912-9917
25. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM: Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997, 277:570-574
26. Chang M: In situ distribution of hepatitis C virus replicative- intermediate RNA in hepatic tissue and its correlation with liver disease. J Virol 2000, 74:944-955
27. Ferrari E, Wright-Minogue J, Fang JW, Baroudy BM, Lau JY, Hong Z: Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol 1999, 73:1649-1654
28. Lohmann V, Korner F, Herian U, Bartenschlager R: Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 1997, 71:8416-8428
29. Ranjith-Kumar CT, Gajewski J, Gutshall L, Maley D, Sarisky RT, Kao CC: Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis. J Virol 2001, 75:8615-8623
30. Ranjith-Kumar CT, Sarisky RT, Gutshall L, Thomson M, Kao CC: De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities. J Virol 2004, 78:12207-12217
31. Robek MD, Boyd BS, Chisari FV: Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005, 79:3851-3854
32. Gale Jr M, Foy EM: Evasion of intracellular host defense by hepatitis C virus. Nature 2005, 436:939-945
33. Agnello V, Abel G, Knight GB, Muchmore E: Detection of widespread hepatocyte infection in chronic hepatitis C. Hepatology 1998, 28:573-584
34. Pileri P: Binding of hepatitis C virus to CD81. Science 1998, 282:938-941
35. Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T: CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA 2004, 101:7270-7274
36. Major ME, Mihalik K, Fernandez J, Seidman J, Kleiner D, Kolykhalov AA, Rice CM, Feinstone SM: Long-term follow-up of chimpanzees inoculated with the first infectious cione for hepatitis C virus. J Virol 1999, 73:3317-3325
37. Hong Z, Beaudet-Miller M, Lanford RE, Guerra B, Wright-Minogue J, Skelton A, Baroudy BM, Reyes GR, Lau JY: Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology 1999, 256:36-44
38. Blight KJ, Kolykhalov AA, Rice CM: Efficient initiation of HCV RNA replication in cell culture. Science 2000, 290:1972-1974
39. Blight KJ, McKeating JA, Marcotrigiano J, Rice CM: Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 2003, 77:3181-3190
40. Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Kumada H: Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C. J Gastroenterol 2000, 35:221-225
41. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, Fujita T, Saito T, Lee WM, Hagedorn CH, Lau DT, Weinman SA, Lemon SM, Gale Jr M: Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci USA 2006, 103:6001-6006
42. Li K, Chen Z, Kato N, Gale Jr M, Lemon SM: Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J Biol Chem 2005, 280:16739-16747
43. Cheng G, Zhong J, Chisari FV: Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2006, 103:8499-8504
44. Hofgartner WT, Polyak SJ, Sullivan DG, Carithers Jr RL, Gretch DR: Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 1997, 53:118-126